Population pharmacokinetics of epinastine, a histamine H₁ receptor antagonist, in adults and children

Abstract

A PPK model for epinastine was established and further evaluation by bootstrapping indicated that this model is stable. The model shows that, if dosage is adjusted based on the body weight, the epinastine exposure in paediatric patients is similar to that in adults.